[Clinical trial of Ercevit P].
D000328:Adult; D000368:Aged; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002208:Caproates / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D005627:Frostbite / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009705:Nucleosides / Q000627:therapeutic use; D010689:Phlebitis / Q000188:drug therapy; D012431:Rutin / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D013684:Telangiectasis / Q000188:drug therapy; D014647:Varicose Ulcer / Q000188:drug therapy; D014648:Varicose Veins / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D002208:Caproates; D002951:Citrates; D005419:Flavonoids; D009705:Nucleosides; D012431:Rutin; D001205:Ascorbic Acid
Essai clinique de l'Ercévit.